Despite declining revenues, investors puzzlingly keep P/S fr...
Despite declining revenues, investors puzzlingly keep P/S from dropping, a move that appears unsustainable. The company's potential overvaluation via P/S ratio amidst poor revenue outlook suggests a premium might be paid for the stock.
Lushang Freda Pharmaceutical Co.,Ltd.'s (SHSE:600223) Shares May Have Run Too Fast Too Soon
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment